Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000938206-24-000035
Filing Date
2024-11-14
Accepted
2024-11-14 11:16:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 13gtemplate.htm SC 13G 50614
  Complete submission text file 0000938206-24-000035.txt   52378
Mailing Address 25 EAST ERIE ST CHICAGO IL 60611
Business Address 25 EAST ERIE ST CHICAGO IL 60611 3125873800
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000938206 (see all company filings)

EIN.: 203634295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Subject) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94122 | Film No.: 241458701
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)